Ticker: CNTA

Centessa Pharmaceuticals plc (NASDAQ: CNTA) - quick inside look What's happening inside * Management has pivoted capital and focus toward its OX2R (orexin receptor 2) agonist franchise (ORX750, ORX142, ORX489) after discontinuing several prior programs (SerpinPC and LB101). * The company out‑lice...

Company Overview Centessa Pharmaceuticals plc (NASDAQ: CNTA) is a clinical-stage pharmaceutical company based in the UK, focused on developing innovative therapies for unmet medical needs. The company's strategy leverages a differentiated asset-centric approach to build a diverse pipeline aimed a...